Patents by Inventor Kyu-Dae Lee

Kyu-Dae Lee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10927085
    Abstract: Disclosed are a compound represented by Formula (1) below, or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3,and Xi to X6 are the same as defined in claim 1.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: February 23, 2021
    Assignee: HUEN Co., Ltd.
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Patent number: 10766882
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.
    Type: Grant
    Filed: April 23, 2018
    Date of Patent: September 8, 2020
    Assignee: YUNGJIN PHARM CO., LTD.
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Publication number: 20180258079
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in claim 1.
    Type: Application
    Filed: April 23, 2018
    Publication date: September 13, 2018
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Patent number: 9975883
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.
    Type: Grant
    Filed: December 30, 2014
    Date of Patent: May 22, 2018
    Assignee: YUNGJIN PHARM. CO., LTD.
    Inventors: Whee Seong Lee, Mi Jung Lee, Bo Jung Kim, Tae Cheul Roh, Seung Hoon Lee, Kyu Dae Lee, You-Hui Lee, Tae Hwan Kwak
  • Publication number: 20160376258
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R6, X1 to X4, and n are the same as defined in Claim 1.
    Type: Application
    Filed: December 30, 2014
    Publication date: December 29, 2016
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK
  • Publication number: 20160376243
    Abstract: Disclosed are a compound represented by Formula (1), or a pharmaceutically acceptable salt, hydrate, solvate, prodrug, tautomer, enantiomer, or pharmaceutically acceptable diastereomer thereof, a method of preparing the same, and a pharmaceutical composition, which have effects for treatment or prevention of metabolic syndromes, comprising the same: wherein R1 to R3, and X1 to X6 are the same as defined in Claim 1.
    Type: Application
    Filed: December 30, 2014
    Publication date: December 29, 2016
    Applicant: KT&G LIFE SCIENCES CORPORATION
    Inventors: Whee Seong LEE, Mi Jung LEE, Bo Jung KIM, Tae Cheul ROH, Seung Hoon LEE, Kyu Dae LEE, You-Hui LEE, Tae Hwan KWAK
  • Patent number: 9250177
    Abstract: A urine analysis device includes a light emitting part, a light receiving part and a control part. The light emitting part includes a plurality of light emitting diodes. The light emitting diodes provide a light to an inspected object. The inspected object has a plurality of inspected areas. The light receiving part receives the light reflected by the inspected object. The control part drives the light emitting part and receives an electric signal from the light receiving part.
    Type: Grant
    Filed: September 8, 2011
    Date of Patent: February 2, 2016
    Assignee: DAE KYOUNG IND. CO., LTD.
    Inventors: Kyu-Dae Lee, Jae-Hoon Song, In-Hyuk Cha
  • Publication number: 20140185050
    Abstract: A urine analysis device includes a light emitting part, a light receiving part and a control part. The light emitting part includes a plurality of light emitting diodes. The light emitting diodes provide a light to an inspected object. The inspected object has a plurality of inspected areas. The light receiving part receives the light reflected by the inspected object. The control part drives the light emitting part and receives an electric signal from the light receiving part.
    Type: Application
    Filed: September 8, 2011
    Publication date: July 3, 2014
    Applicant: DAE KYOUNG IND. CO., LTD.
    Inventors: Kyu-Dae Lee, Jae-Hoon Song, In-Hyuk Cha
  • Patent number: D703827
    Type: Grant
    Filed: September 11, 2013
    Date of Patent: April 29, 2014
    Assignee: Dae Kyoung Ind. Co., Ltd
    Inventor: Kyu-Dae Lee